Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 3 Amino Butanol. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109608344A details efficient chiral resolution for (R)-3-amino butanol. Offers cost reduction and scalable supply for pharmaceutical intermediates manufacturing.
Patent CN106754806B discloses a high-efficiency transaminase for synthesizing (R)-3-aminobutanol, offering superior substrate tolerance and eliminating organic cosolvents for cost-effective manufacturing.
Novel patent CN106966912B enables efficient Dolutegravir intermediate production with high optical purity and scalable manufacturing processes for global supply chains.
Patent CN104131048A reveals high-yield biological synthesis for chiral intermediates. Achieve superior purity and cost efficiency in pharmaceutical manufacturing supply chains.
Patent CN116515782A reveals a novel amine dehydrogenase mutant for high-purity chiral amine alcohol production, offering significant cost and safety advantages.
Patent CN110551771A reveals green enzymatic synthesis using 1,3-butanediol. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN110668958A reveals a high-purity synthesis route for (R)-3-aminobutanol, a key Dolutegravir intermediate, offering significant cost and supply chain advantages.
Patent CN108823179A reveals high-efficiency transaminase mutant for R-3-aminobutanol, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN104178533B details enzymatic synthesis of R-3-aminobutanol. Offers high purity, cost efficiency, and scalable supply chain solutions for global pharmaceutical manufacturers.
Patent CN108689866A reveals a safer synthetic route for (R)-3-amino butanols. Achieve high purity and yield with reduced operational risks for HIV drug intermediates.
Patent CN110551771B details a green enzymatic route for chiral 3-amino-1-butanol. Discover cost-effective, high-purity pharmaceutical intermediate manufacturing solutions.
Patent CN104370755A reveals efficient synthesis for Dolutegravir intermediates. Enables cost reduction and scalable supply chain for global pharmaceutical manufacturers.
Patent CN110358804B reveals high-purity enzymatic resolution for dolutegravir synthesis, offering scalable biocatalysis solutions for reliable pharmaceutical intermediate suppliers.
Patent CN115594600A reveals a safer, one-step synthesis of chiral (R)-3-aminobutanol using borohydride, offering significant cost reduction and supply chain reliability for API manufacturers.
Novel biocatalytic method for (S)-2-amino-1-butanol and (R)-3-amino-1-butanol using amine dehydrogenases. High yield, mild conditions, scalable process for pharmaceutical intermediates.
Patent CN104961640A reveals a cost-effective rhodium-catalyzed synthesis route for high-purity chiral intermediates, ensuring supply chain stability and safety.
Patent CN115322106B details a novel high-selectivity synthesis route. Achieve cost reduction in pharmaceutical intermediate manufacturing with scalable, mild conditions.